China Resources Pharmaceutical Group Ltd. (DE:640)
FRANKFURT:640
Total Valuation
China Resources Pharmaceutical Group Ltd. has a market cap or net worth of €3.32B. The enterprise value is €103.60B.
Market Cap€3.32B
Enterprise Value€103.60B
Share Statistics
China Resources Pharmaceutical Group Ltd. has 6,282,510,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,282,510,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Resources Pharmaceutical Group Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.74%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)4.74%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee4.13M
Profits Per Employee162.25K
Employee Count72,700
Asset Turnover0.94
Inventory Turnover5.20
Valuation Ratios
The current PE Ratio of China Resources Pharmaceutical Group Ltd. is 6.6. China Resources Pharmaceutical Group Ltd.’s PEG ratio is 0.22.
PE Ratio6.6
PS Ratio0.09
PB Ratio0.49
Price to Fair Value0.49
Price to FCF1.65
Price to Operating Cash Flow1.50
PEG Ratio0.22
Income Statement
In the last 12 months, China Resources Pharmaceutical Group Ltd. had revenue of 300.01B and earned 4.50B in profits. Earnings per share was 0.72.
Revenue300.01B
Gross Profit49.53B
Operating Income13.90B
Pretax Income13.13B
Net Income4.50B
EBITDA17.70B
Earnings Per Share (EPS)0.72
Cash Flow
In the last 12 months, operating cash flow was 19.77B and capital expenditures -2.46B, giving a free cash flow of 17.31B billion.
Operating Cash Flow19.77B
Free Cash Flow17.31B
Free Cash Flow per Share2.76
Dividends & Yields
China Resources Pharmaceutical Group Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.23
52-Week Price Change-6.19%
50-Day Moving Average0.57
200-Day Moving Average0.52
Relative Strength Index (RSI)48.90
Average Volume (3m)66.00
Important Dates
China Resources Pharmaceutical Group Ltd. upcoming earnings date is Mar 25, 2026, TBA (Not Confirmed).
Last Earnings DateAug 26, 2025
Next Earnings DateMar 25, 2026
Ex-Dividend Date―
Financial Position
China Resources Pharmaceutical Group Ltd. as a current ratio of 1.42, with Debt / Equity ratio of 183.14%
Current Ratio1.42
Quick Ratio1.11
Debt to Market Cap3.72
Net Debt to EBITDA4.20
Interest Coverage Ratio6.33
Taxes
In the past 12 months, China Resources Pharmaceutical Group Ltd. has paid 2.38B in taxes.
Income Tax2.38B
Effective Tax Rate0.18
Enterprise Valuation
China Resources Pharmaceutical Group Ltd. EV to EBITDA ratio is 5.78, with an EV/FCF ratio of 6.04.
EV to Sales0.34
EV to EBITDA5.78
EV to Free Cash Flow6.04
EV to Operating Cash Flow4.99
Balance Sheet
China Resources Pharmaceutical Group Ltd. has €58.73B in cash and marketable securities with €104.87B in debt, giving a net cash position of -€46.14B billion.
Cash & Marketable Securities€58.73B
Total Debt€104.87B
Net Cash-€46.14B
Net Cash Per Share-€7.34
Tangible Book Value Per Share€14.51
Margins
Gross margin is 16.51%, with operating margin of 4.63%, and net profit margin of 1.50%.
Gross Margin16.51%
Operating Margin4.63%
Pretax Margin4.38%
Net Profit Margin1.50%
EBITDA Margin5.90%
EBIT Margin4.69%
Analyst Forecast
The average price target for China Resources Pharmaceutical Group Ltd. is €0.74, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€0.74
Price Target Upside50.54% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast0.35%
EPS Growth Forecast16.08%